期刊文献+

晚期乳腺癌及复发性乳腺癌的介入治疗 被引量:2

Interventional therapy for advanced breast cancer and recurred breast cancer
暂未订购
导出
摘要 目的 研究晚期乳腺癌及术后复发性乳腺癌的介入治疗方法及其临床意义。方法 对 2 4例患者先行患侧锁骨下动脉造影 ,确定病灶的供血动脉 ,然后超选择插管 ,根据病灶的大小及血供情况注入抗癌药物。结果 乳腺癌原发灶、转移淋巴结及复发病灶 ,均有多支动脉供血 ,其中胸外侧动脉、胸背动脉及内乳动脉是最常见的供血动脉。介入治疗完全缓解率 (CR)为 16 .7% (4/2 4) ,部分缓解率 (PR)为 6 2 .5 % (15 /2 4) ,有效率为 79.2 % (19/2 4)。并使部分不可手术乳腺癌 ,介入治疗后可以手术治疗。毒副作用较轻。结论 介入治疗可了解病灶的供血 。 Objective To study the effect of interventional treatment on advanced breast cancer and recurred breast cancer.Methods Digital subtraction angiography of the subclavian artery was performed in 24 cases to find out the vascular supply to the lesions,then superselective cantheterization was performed before the arterial infusion of anti cancerous agents according to the blood supply and the size of the lesions.Results The vascular supply of the primary breast cancer,recurred tumor and metastatic lymph node came from lateral thoracic artery, thoracodorsal artery and internal thoracica artery.The complete response rate(CR)was 16.7%(4/24)and the partial response rate (PR)was 62.5%(15/24),the total effective rate was 79.2%(19/24).Side effects due to this treatment were few.Conclusions Interventional therapy may help to find out the blood supply of the lesions, and it is effective on and recurred breast cancer.
出处 《中国肿瘤临床与康复》 2001年第2期110-111,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 复发癌 介入性化疗 乳腺癌 治疗 breast neoplasm recurrence interventional chemotherapy
  • 相关文献

参考文献2

二级参考文献2

共引文献17

同被引文献21

  • 1官静,刘丽江.乳腺癌组织芯片的应用与HER-2/neu的表达[J].江汉大学学报(自然科学版),2004,32(2):5-8. 被引量:1
  • 2甘长清,苏新良,杨光伦,吴诚义,吴凯南.经尺动脉介入化疗治疗局部晚期乳腺癌27例临床分析[J].重庆医学,2005,34(3):407-408. 被引量:8
  • 3柳金彬.Ⅲ期乳腺癌应用动脉导管灌注的新辅助化疗[J].实用肿瘤学杂志,1995,9(3):53-54. 被引量:13
  • 4汤钊猷主编.现代肿瘤学[M]. 上海医科大学出版社, 1993
  • 5T. Cooke,J. Reeves,A. Lanigan,P. Stanton.HER2 as a prognostic and predictive marker for breast cancer[J].Annals of Oncology.2001(1)
  • 6Smith IC,Heys SD,Hutcheon AW,et al.Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel[].Journal of Clinical Oncology.2002
  • 7F Maloisel,P Dufour,JP Bergerat.Results of initial doxorubicin, 5-fluorouracil and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast[].Cancer.1990
  • 8G Bonadonna,A Moliterni,M Zambetti,MG Daidone,S Pilotti,L Gianni,P Valagussa.30 years’ follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study[].British Medical Journal.2005
  • 9Slamon DJ,Godolphin W,Jone LA,et al.Studied of the HER-2 /neu proto-oncogen in human breast and overian cancer[].Science.1998
  • 10Cooke T,Reves J,Lanigan A,et al.HER2 as a prognostic and predictive marker for breast cancer[].Ann Oncol.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部